Microbubble
Microbubble-Mediated Sonothrombolysis Improves Outcome After Thrombotic Microembolism–Induced Acute Ischemic Stroke
Clinical Question
Can microbubble-mediated sonothrombolysis improve outcomes after microthrombi-induced acute ischemic stroke?
Bottom Line
Microbubble-mediated sonothrombolysis significantly reduced infarct volume and improved neurologic function in rat stroke models without increasing hemorrhagic risk.
Major Points
- Rats with embolic stroke from microthrombi were treated with combinations of ultrasound, microbubbles, and r-tPA
- US+MB therapy was effective for both platelet-rich and erythrocyte-rich microthrombi
- Infarct volumes and neurological deficits were significantly reduced with US+MB compared to control or r-tPA alone
- No intracerebral hemorrhage was observed after US+MB treatment
- Platelet-rich thrombi were resistant to r-tPA but responsive to US+MB
Design
Study Type: Preclinical, in vivo rat stroke model
Randomization: 1
Blinding: Blinded outcome assessment
Enrollment Period: Not applicable (animal model)
Follow-up Duration: 24 hours post-stroke
Centers: 1
Countries: China
Sample Size: 125
Analysis: ANOVA, Kruskal–Wallis, Fisher exact test, blinded observers
Inclusion Criteria
- Male Sprague–Dawley rats
- Induced mesenteric thrombosis or embolic cerebral ischemia from microthrombi
- 70–100 μm thrombi derived from platelet-rich or erythrocyte-rich clots
Exclusion Criteria
- None reported (animal model)
Baseline Characteristics
| Characteristic | Control | Active |
|---|---|---|
| Neurological Score (24h) | 2–3 | |
| Infarct Volume (White Thrombi, MRI) | 26.9 ± 3.1% | 9.5 ± 3.0% |
| Infarct Volume (Red Thrombi, MRI) | 24.6 ± 3.1% | 8.6 ± 2.8% |
| Neurological Score (24h, US+MB) | 1 |
Arms
| Field | US+MB | r-tPA | US+MB+r-tPA | Ultrasound alone | Control |
|---|---|---|---|---|---|
| Intervention | Ultrasound (2 MHz, 30 min) + IV microbubbles (0.008 mL/min) | 10 mg/kg IV r-tPA (bolus + 30-min infusion) | Ultrasound + IV microbubbles + half-dose r-tPA (5 mg/kg) | Ultrasound (2 MHz, 30 min) without microbubbles | No active treatment |
| Duration | 30 minutes | 30 minutes | 30 minutes | 30 minutes | N/A |
Outcomes
| Outcome | Type | Control | Intervention | HR / OR / RR | P-value |
|---|---|---|---|---|---|
| Cerebral infarct volume at 24 hours (MRI/TTC) | Primary | White: 26.9%, Red: 24.6% | White: 9.5%, Red: 8.6% (US+MB) | 17.40% | <0.01 |
| Neurological score at 24h | Secondary | Score 2–3 | Score 1 (US+MB) | <0.01 | |
| Recanalization of mesenteric vessels | Secondary | 0% | >75% (US+MB) | <0.05 | |
| Intracerebral Hemorrhage | Adverse | 0% | 0% | NS |
Subgroup Analysis
US+MB was effective in both platelet-rich and erythrocyte-rich microthrombi; r-tPA alone was ineffective for platelet-rich microthrombi
Criticisms
- Animal study — findings may not translate directly to humans
- Short 24-hour follow-up period; late hemorrhage not assessed
- Used only fresh thrombi — older thrombi may behave differently
Funding
National Basic Research Program of China, National Natural Science Foundation of China, Guangdong Province Team Program
Based on: Microbubble (Stroke, 2016)
Authors: Yongkang Lu, Junfen Wang, Ruizhu Huang, ..., Jianping Bin
Citation: Stroke. 2016;47:1344–1353. doi:10.1161/STROKEAHA.115.012056
Content summarized and formatted by NeuroTrials.ai.